This story was originally published by KFF Health News. While customers at Adams Family Pharmacy picked up their ...

Employers worried about lawsuits from workers charging they're not spending their health care dollars wisely are increasingly ...

The rebate game played by drug makers and pharmacy benefit managers limits optimal biosimilar competition. As a result, U.S.

Analyst Allen Lutz of Bank of America Securities reiterated a Sell rating on GoodRx Holdings (GDRX – Research Report), reducing the price ...

The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...

GoodRx has been hit with a series of antitrust class actions in California and Rhode Island federal courts challenging the ...

Part 1 of this 3-part series for Global Biosimilars Week focuses on legal barriers to biosimilar access in the US, including the patent system, and discusses ongoing legislative efforts to address ...

CVS Health fell short on third-quarter profit, but it posted strong sales and the health care giant shook up leadership under ...

The pharmacy benefit management (PBM) ecosystem is deeply broken. Not only does the current system lead to ultra-high pricing, particularly for specialty drugs, but it puts employees last, plain and ...

The review of Minnesota-based Optum’s business practices by the Mississippi Board of Pharmacy indicated that the company paid independent pharmacies in Mississippi rates lower than chains and ...

The Rio-based network of independent pharmacies blames drug industry intermediaries known as pharmacy benefit managers.